<SEC-DOCUMENT>0001752724-24-283803-index.html : 20241216
<SEC-HEADER>0001752724-24-283803.hdr.sgml : 20241216
<ACCEPTANCE-DATETIME>20241216114820
ACCESSION NUMBER:		0001752724-24-283803
CONFORMED SUBMISSION TYPE:	N-CEN
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20240930
FILED AS OF DATE:		20241216
DATE AS OF CHANGE:		20241216
EFFECTIVENESS DATE:		20241216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			abrdn Life Sciences Investors
		CENTRAL INDEX KEY:			0000884121
		ORGANIZATION NAME:           	
		IRS NUMBER:				043147016
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		N-CEN
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-06565
		FILM NUMBER:		241550795

	BUSINESS ADDRESS:	
		STREET 1:		1900 MARKET STREET
		STREET 2:		SUITE 200
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		1900 MARKET STREET
		STREET 2:		SUITE 200
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TEKLA LIFE SCIENCES INVESTORS
		DATE OF NAME CHANGE:	20141015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H&Q LIFE SCIENCES INVESTORS
		DATE OF NAME CHANGE:	19920929
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-CEN
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>MATERIAL AMENDMENTS
<SEQUENCE>2
<FILENAME>NCEN_811-06565_13453533_0924.htm
<TEXT>
Document 2 - file: NCEN_811-06565_13453533_0924.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>ITEM 405 REG S-K
<SEQUENCE>3
<FILENAME>NCEN_811-06565_18338061_0924.htm
<TEXT>
Document 3 - file: NCEN_811-06565_18338061_0924.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>INTERNAL CONTROL RPT
<SEQUENCE>4
<FILENAME>NCEN_811-06565_84958532_0924.htm
<TEXT>
Document 4 - file: NCEN_811-06565_84958532_0924.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>ADVISORY CONTRACTS
<SEQUENCE>5
<FILENAME>NCEN_811-06565_91299306_0924.htm
<TEXT>
Document 5 - file: NCEN_811-06565_91299306_0924.htm

</DOCUMENT>
</SEC-DOCUMENT>